SYNTHETIC DEMONSTRATION — no real student or patient. Not a medical device.

fertility

Blood Clotting Disorders and Recurrent Pregnancy Loss: What to Know

Antiphospholipid syndrome (APS) is the most important and treatable clotting-related cause of recurrent pregnancy loss. This autoimmune condition produces antibodies that promote clotting and impair placental development. Treatment with low-dose aspirin and heparin significantly improves live birth rates when APS is diagnosed [3].

Talk to a clinician

Gale can match you with a licensed clinician for a visit.

Find care →

What is antiphospholipid syndrome and how does it cause miscarriage?

Antiphospholipid syndrome is an autoimmune condition in which the immune system produces antibodies — most commonly lupus anticoagulant, anticardiolipin antibodies (aCL), and anti-beta-2-glycoprotein I antibodies — that mistakenly attack proteins bound to phospholipids (fats in cell membranes). This increases the tendency for blood to clot and can disrupt the development of the placenta and its blood supply early in pregnancy.

APS is associated with: - Recurrent early miscarriage (before 10 weeks) - Later pregnancy losses (10 weeks and beyond) - Severe preeclampsia - Placental insufficiency - Blood clots in veins or arteries outside of pregnancy

APS is one of the few identifiable and treatable causes of recurrent pregnancy loss, which is why testing for it is a consistent recommendation in the RPL evaluation. [1, 2]

How is antiphospholipid syndrome diagnosed?

APS is diagnosed by a combination of clinical criteria (a history of clotting or pregnancy loss) and laboratory findings. Because these antibodies can be transiently present during illness or for other reasons, a positive result must be confirmed on a second test at least 12 weeks after the first — a requirement established by the international Sydney classification criteria. A single positive test is not sufficient for diagnosis. 2

The three antibody tests are: 1. Lupus anticoagulant (LA): Detected through a panel of clotting time tests (not a single test) 2. Anticardiolipin antibodies (aCL): IgG and IgM subtypes, at medium-to-high titer 3. Anti-beta-2-glycoprotein I antibodies (anti-β2GPI): IgG and IgM subtypes

Having two or three positive tests ("triple positivity") carries a higher risk than a single positive, and the clinical weight given to low-titer positives versus high-titer positives varies 2. Your reproductive endocrinologist will interpret these results in the context of your full history.

How is APS treated during pregnancy?

For people with confirmed APS and a history of recurrent pregnancy loss, the standard treatment during pregnancy is a combination of: - Low-dose aspirin (typically 81 mg daily), started before conception or early in pregnancy - Low-molecular-weight heparin (such as enoxaparin) — a blood thinner that does not cross the placenta, injected under the skin

A 2021 systematic review and meta-analysis found that heparin, with or without aspirin, significantly increased the live birth rate and reduced the risk of preeclampsia compared to any other comparator, without increasing serious maternal or neonatal adverse effects. 3 Treatment is typically continued through delivery and for several weeks postpartum, since the clotting risk remains elevated after birth.

If you have not previously been diagnosed with APS but test positive as part of an RPL evaluation, your specialist will discuss the appropriate treatment approach based on your specific antibody profile and pregnancy history.

What about inherited thrombophilias like Factor V Leiden?

Inherited thrombophilias are genetic variations that increase blood clotting tendency. The most common include Factor V Leiden mutation, prothrombin gene mutation, and protein C, protein S, or antithrombin deficiencies.

The link between these inherited thrombophilias and recurrent pregnancy loss is more complicated and debated than with APS. While some observational studies have found associations, rigorous randomized trials have not consistently shown that treating inherited thrombophilias with heparin reduces miscarriage rates in the absence of other factors. 1

ASRM guidance does not currently recommend routine screening for inherited thrombophilias as a standard part of the RPL workup, though individual clinicians and specialists may offer it in certain clinical situations — particularly when there is a personal or strong family history of blood clots. If you have already been told you carry Factor V Leiden or another thrombophilia, discuss it explicitly with your reproductive endocrinologist in the context of your specific history.

Should I see a specialist, or can my OB-GYN manage this?

APS in pregnancy is managed best by a team: a reproductive endocrinologist or maternal-fetal medicine (MFM) specialist, and often a hematologist or rheumatologist who has confirmed the diagnosis. Once you are pregnant with a confirmed APS diagnosis, an MFM specialist (also called a perinatologist) typically oversees high-risk pregnancy monitoring.

For the diagnostic evaluation after two losses, a reproductive endocrinologist is the specialist most experienced in ordering and interpreting the full RPL workup, including APS testing 1. Gale can help you find a specialist and prepare questions for your appointment.

Common questions

Can APS cause miscarriage even without causing blood clots elsewhere?

Yes. Pregnancy loss is one of the recognized clinical manifestations of APS and can occur in the absence of a history of blood clots in veins or arteries. Recurrent pregnancy loss alone, with confirmed antibodies on two tests, meets diagnostic criteria for obstetric APS.

Do I need to be tested for APS after every miscarriage?

Testing is most meaningful in the context of recurrent loss (two or more). A one-time positive result always requires a second confirmatory test 12 or more weeks later, since transient positives can occur. Your clinician will time the testing appropriately.

If I test positive for APS antibodies but have no history of pregnancy loss or blood clots, do I need treatment?

Incidentally discovered APS antibodies without clinical events are a complex situation that requires specialist input. Treatment decisions are individualized based on antibody levels, combination of positive tests, and other risk factors.

Is Factor V Leiden routinely tested in the RPL workup?

Not as a standard recommendation per ASRM guidance, because the evidence that treating it prevents miscarriage is not strong. It may be offered based on individual history or if your clinician has specific clinical reasons to look for it.

Can a clotting disorder be found and treated before I get pregnant again?

Yes. Testing can be done and APS confirmed outside of pregnancy. Starting aspirin and planning for heparin from early pregnancy (ideally from a positive pregnancy test) is the standard approach when APS is known in advance.

Talk to a clinician

Gale can match you with a licensed clinician for a visit.

Find care →

Signs that need prompt attention during pregnancy with APS

  • —Sudden leg pain, swelling, or redness — possible deep vein thrombosis
  • —Shortness of breath or chest pain — possible pulmonary embolism; call 911
  • —Sudden severe headache, vision changes, or neurologic symptoms — possible stroke
  • —Bleeding that is unusual or heavy while on aspirin or heparin — contact your care team

Blood clot emergencies are life-threatening. If you experience sudden chest pain, difficulty breathing, or leg swelling with pain, call 911 immediately.

This article is general health education, not personalized medical advice. Antiphospholipid syndrome diagnosis and management require specialist evaluation by a reproductive endocrinologist, maternal-fetal medicine specialist, rheumatologist, or hematologist.

References

  1. 1.Practice Committee of the American Society for Reproductive Medicine (2012). Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertility and Sterility. doi:10.1016/j.fertnstert.2012.06.048 ✓ASRM committee opinion on recurrent pregnancy loss: APS as a standard evaluation component, diagnostic criteria requiring confirmation on two tests, aspirin and heparin treatment, and cautious guidance on inherited thrombophilias
  2. 2.Miyakis S, Lockshin MD, Atsumi T, et al. (2006). International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Journal of Thrombosis and Haemostasis. doi:10.1111/j.1538-7836.2006.01753.x ✓International Sydney consensus criteria for definite APS diagnosis: requires clinical history plus laboratory confirmation (on two occasions at least 12 weeks apart) of lupus anticoagulant, anticardiolipin, or anti-β2GPI antibodies at medium-to-high titer
  3. 3.Guerby P, Fillion A, O'Connor S, Bujold E (2021). Heparin for preventing adverse obstetrical outcomes in pregnant women with antiphospholipid syndrome, a systematic review and meta-analysis. Journal of Gynecology Obstetrics and Human Reproduction. doi:10.1016/j.jogoh.2020.101974 ✓Systematic review and meta-analysis: heparin (with or without aspirin) significantly increased live birth rates and reduced preeclampsia in pregnant women with APS, without increasing serious adverse maternal or neonatal outcomes
  4. 4.American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Gynecology (2018). ACOG Practice Bulletin No. 200: Early Pregnancy Loss. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000002899 ✓ACOG Practice Bulletin: APS as a recognized and treatable cause of pregnancy loss included in the clinical evaluation of early and recurrent pregnancy loss

4 sources, numbered by first appearance. General health information, not medical advice — synthetic demonstration content.